Cleared Traditional

STREP D FLUOR (K860041) - FDA 510(k) Clearance

Class I Microbiology device.

K860041 · Bio Spec, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1986
Decision
18d
Days
Class 1
Risk

K860041 is an FDA 510(k) clearance for the STREP D FLUOR. Classified as Exoenzymes, Multiple, Streptococcal (product code GTP), Class I - General Controls.

Submitted by Bio Spec, Inc. (Concord, US). The FDA issued a Cleared decision on January 24, 1986 after a review of 18 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3720 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bio Spec, Inc. devices

Submission Details

510(k) Number K860041 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 06, 1986
Decision Date January 24, 1986
Days to Decision 18 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
84d faster than avg
Panel avg: 102d · This submission: 18d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code GTP Exoenzymes, Multiple, Streptococcal
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3720
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.